Clinical trial
MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial
NCT06541249 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- October 2, 2024
- Completion date
- December 31, 2027
- Enrollment
- 54 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
essential thrombocythemia (et), myelofibrosis (mf), polycythemia vera (pv)